Centennial Wealth Advisory LLC Purchases 7,637 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Centennial Wealth Advisory LLC lifted its position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 44.6% in the fourth quarter, Holdings Channel.com reports. The institutional investor owned 24,750 shares of the pharmacy operator’s stock after buying an additional 7,637 shares during the period. Centennial Wealth Advisory LLC’s holdings in Walgreens Boots Alliance were worth $231,000 at the end of the most recent quarter.

Other large investors have also made changes to their positions in the company. First Financial Corp IN increased its holdings in Walgreens Boots Alliance by 49.2% during the 4th quarter. First Financial Corp IN now owns 2,685 shares of the pharmacy operator’s stock worth $25,000 after purchasing an additional 885 shares in the last quarter. TD Private Client Wealth LLC increased its holdings in Walgreens Boots Alliance by 8,670.3% during the 3rd quarter. TD Private Client Wealth LLC now owns 3,245 shares of the pharmacy operator’s stock worth $29,000 after purchasing an additional 3,208 shares in the last quarter. Sentry Investment Management LLC bought a new position in shares of Walgreens Boots Alliance in the 3rd quarter valued at about $30,000. Eastern Bank bought a new position in shares of Walgreens Boots Alliance in the 3rd quarter valued at about $33,000. Finally, Brooklyn Investment Group bought a new position in shares of Walgreens Boots Alliance in the 3rd quarter valued at about $35,000. Institutional investors own 58.59% of the company’s stock.

Walgreens Boots Alliance Price Performance

Shares of WBA stock opened at $10.12 on Thursday. The firm has a 50 day moving average price of $10.16 and a two-hundred day moving average price of $9.82. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.30 and a current ratio of 0.64. Walgreens Boots Alliance, Inc. has a 12-month low of $8.08 and a 12-month high of $23.76.

Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings results on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share for the quarter, beating analysts’ consensus estimates of $0.38 by $0.13. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. The company had revenue of $39.50 billion during the quarter, compared to the consensus estimate of $37.40 billion. During the same period in the previous year, the business earned $0.66 earnings per share. The firm’s quarterly revenue was up 7.6% on a year-over-year basis. Research analysts predict that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current year.

Analyst Upgrades and Downgrades

WBA has been the subject of several analyst reports. Morgan Stanley decreased their price objective on Walgreens Boots Alliance from $9.00 to $7.00 and set an “underweight” rating for the company in a report on Friday, October 11th. UBS Group raised their target price on shares of Walgreens Boots Alliance from $9.00 to $10.00 and gave the company a “neutral” rating in a research note on Thursday, October 17th. Evercore ISI raised their target price on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the company an “in-line” rating in a research note on Monday, January 13th. TD Cowen cut their target price on shares of Walgreens Boots Alliance from $16.00 to $14.00 and set a “buy” rating for the company in a research note on Tuesday, October 22nd. Finally, Truist Financial cut their target price on shares of Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating for the company in a research note on Friday, January 31st. Four investment analysts have rated the stock with a sell rating, nine have given a hold rating and two have given a buy rating to the company. Based on data from MarketBeat, Walgreens Boots Alliance presently has a consensus rating of “Hold” and an average price target of $13.19.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.